Stocktoria

PepGen Inc. PEPG

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2022-05-06

PepGen Inc. statistics & valuation

Market cap$117.6M
P / B0.8×
Return on equity-60.8%
Return on capital-58%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20212022202320242025
Operating margin (%)
20212022202320242025
Return on equity (%)
-38.50% -72.50% -75.90% -60.80% 20212022202320242025
Shares outstanding
963588 23.7M 23.8M 32.6M 68.9M 20212022202320242025
Net debt ($)
20212022202320242025
Share buybacks ($)
20212022202320242025
Return on assets (%)
-19.00% -31.80% -55.00% -59.60% -51.60% 20212022202320242025
Free cash flow margin (%)
20212022202320242025
Debt / equity (×)
20212022202320242025
EPS ($)
-$30.27 -$4.42 -$3.30 -$2.85 -$2.12 20212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021
Return on assets-51.6%-59.6%-55.0%-31.8%-19.0%
Return on equity-60.8%-75.9%-72.5%-38.5%85.0%
Current ratio11.947.416.439.8813.56

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.